ArticleOncotarget2018

IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI.

Hai-Lun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.